Cumberland Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 2.27, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Cumberland Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 161 days, from 113 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 314 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1236 to 1761.

What is Receivable Turnover Ratio?
What is Cumberland Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CPIX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	30.07 %	35.98 %	44.81 %	-7.78 %	-11.21 %
Y / Y Revenue Change	-98.46 %	-22.04 %	31.08 %	-8.73 %	10.04 %
Receivable Turnover Ratio (TTM)	2.27	3.23	3.7	3.85	3.84
CPIX's Total Ranking	# 1761	# 1236	# 1173	# 1673	# 2729
Accounts Receivable average collection period days	161	113	99	95	95
Seq. Receivable Change	-5.91 %	-15.83 %	62.45 %	1.1 %	-1.63 %
Seq. Revenue Change	-98.18 %	-33.24 %	64.95 %	-23.48 %	-7.48 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 86
Healthcare Sector	# 315
Overall Market	# 1761

Receivable Turnover Ratio Statistics
High	Average	Low
0.63	0.43	0.33
(Dec 31 2025)		(Mar 31 2014)

CPIX Company Profile • Back to CPIX Efficiency Comparisons • Compare CPIX Receivables Turnover Ratio to its Competitors

Financial Statements
Cumberland Pharmaceuticals Inc 's Accounts Receivable	$ 13 Millions	Visit CPIX's Balance sheet
Cumberland Pharmaceuticals Inc 's Sales TTM	$ 31 Millions	Visit CPIX's Income Statement
Sources of CPIX's Revenues		Visit CPIX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CPIX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CPIX's Growth Rates	CPIX's Roa	CPIX's Inventory Turnover Ratio	CPIX's Dividend Comparisons
CPIX's Profitability Ratios	CPIX's Roi	CPIX's Asset Turnover Ratio	CPIX's Dividend Growth
CPIX's Valuation Ratios	CPIX's Roe	CPIX's Financial Strength Ratios	CPIX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Macrogenics Inc	6.41	$ 167.674 Millions	$ 26.170 Millions
Bruker Corporation	6.41	$ 3,498.900 Millions	$ 546.100 Millions
Adaptive Biotechnologies Corporation	6.38	$ 308.081 Millions	$ 48.254 Millions
Iradimed Corporation	6.38	$ 86.339 Millions	$ 13.533 Millions
Aquestive Therapeutics Inc	6.37	$ 54.087 Millions	$ 8.489 Millions
Zoetis Inc	6.32	$ 9,517.000 Millions	$ 1,506.750 Millions
Nuwellis Inc	6.28	$ 9.013 Millions	$ 1.435 Millions
Puma Biotechnology Inc	6.27	$ 231.244 Millions	$ 36.902 Millions
Absci Corp	6.24	$ 1.561 Millions	$ 0.250 Millions
Insulet Corporation	6.24	$ 3,053.400 Millions	$ 489.200 Millions
Heartflow Inc	6.22	$ 210.791 Millions	$ 33.872 Millions
Perrigo Company Plc	6.22	$ 4,144.000 Millions	$ 666.050 Millions
Maxcyte inc	6.22	$ 31.051 Millions	$ 4.994 Millions
Vertex Pharmaceuticals Inc	6.19	$ 12,587.200 Millions	$ 2,032.400 Millions
Orthofix Medical Inc	6.17	$ 833.344 Millions	$ 135.037 Millions
Harvard Bioscience Inc	6.16	$ 88.164 Millions	$ 14.306 Millions
Genedx Holdings Corp	6.16	$ 455.446 Millions	$ 73.962 Millions
Gilead Sciences Inc	6.15	$ 30,457.000 Millions	$ 4,951.000 Millions
Integra Lifesciences Holdings Corp	6.14	$ 1,647.666 Millions	$ 268.153 Millions
Clearpoint Neuro Inc	6.13	$ 42.279 Millions	$ 6.902 Millions
Interpace Biosciences Inc	6.12	$ 36.519 Millions	$ 5.963 Millions
Xeris Biopharma Holdings Inc	6.12	$ 335.414 Millions	$ 54.800 Millions
Treace Medical Concepts Inc	6.12	$ 205.307 Millions	$ 33.551 Millions
Cadre Holdings inc	6.11	$ 686.540 Millions	$ 112.443 Millions
Zevra Therapeutics Inc	6.09	$ 128.855 Millions	$ 21.172 Millions
Femasys Inc	6.08	$ 2.299 Millions	$ 0.378 Millions
Lakeland Industries Inc	6.07	$ 190.961 Millions	$ 31.455 Millions
Msa Safety Inc	6.05	$ 1,946.916 Millions	$ 321.572 Millions
Neogen Corporation	6.05	$ 870.190 Millions	$ 143.936 Millions
Pacira Biosciences inc	6.00	$ 746.164 Millions	$ 124.348 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.